Avanos Medical (AVNS) Gross Margin (2013 - 2026)
Avanos Medical (AVNS) posted Gross Margin of 51.7% for Q1 2026, up 8.75% sequentially from 47.54% in Q4 2025, and down 191.0% YoY from 56.81% in Q1 2025.
Avanos Medical (AVNS) Gross Margin (2013 - 2026) Analysis & Trends
Avanos Medical has reported Gross Margin for 14 years, with the latest figure at 51.7% in Q1 2026.
- Quarterly Gross Margin fell 191.0% year-over-year to 51.7% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 50.05% (down 455.0% YoY) and the FY2025 annual result came in at 50.47%, down 497.0% from the prior year.
- Gross Margin climbed to 51.7% in Q1 2026 per AVNS's latest filing, from 47.54% in the prior quarter.
- Over five years, Gross Margin peaked at 59.45% in Q2 2022 and troughed at 47.54% in Q4 2025.
- A 5-year average of 54.68% and a median of 54.82% in 2023 frame the typical range for Gross Margin.
- The widest YoY moves for Gross Margin: up 1347 bps in 2022, down 3356 bps in 2022.
- Over 5 years, Gross Margin stood at 56.66% in 2022, then decreased by 3 bps to 54.82% in 2023, then slipped by 0 bps to 54.57% in 2024, then slipped by 13 bps to 47.54% in 2025, then advanced by 9 bps to 51.7% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 51.7%, 47.54%, and 48.37% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 45.84% |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 51.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.70% |
| Dec 31, 2025 | 47.54% |
| Sep 30, 2025 | 48.37% |
| Jun 30, 2025 | 52.63% |
| Mar 31, 2025 | 53.61% |
| Dec 31, 2024 | 54.57% |
| Sep 30, 2024 | 54.52% |
| Jun 30, 2024 | 55.68% |
| Mar 31, 2024 | 57.07% |
| Dec 31, 2023 | 54.82% |
| Sep 30, 2023 | 55.75% |
| Jun 30, 2023 | 57.73% |
| Mar 31, 2023 | 57.38% |
| Dec 31, 2022 | 56.66% |
| Sep 30, 2022 | 58.15% |
| Jun 30, 2022 | 59.45% |
| Mar 31, 2022 | 54.00% |
| Dec 31, 2021 | 90.22% |
| Sep 30, 2021 | 49.00% |
| Jun 30, 2021 | 45.98% |